Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
human monoclonal antibody that binds to theprotein CTLA-4, under investigation to treat various kinds oftumour .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word tremelimumab.
Examples
-
"We continue to focus on additional studies involving tremelimumab alone and in combination with other therapies which are currently ongoing in patients with several types of cancer."
-
Of Melanoma Treatment Pfizer Inc. has ended a Phase III clinical trial of tremelimumab in patients with advanced melanoma after a review of interim data showed that the drug was not better than standard chemotherapy.
-
MedImmune plans to explore tremelimumab in a number of potential cancer indications.
unknown title 2011
-
Under the terms of this agreement, MedImmune will assume global development rights to tremelimumab and Pfizer will retain the rights to use tremelimumab with specified types of combination therapies.
unknown title 2011
-
Anders Ekblom, AstraZeneca's Executive Vice President, Global Medicines Development, added: "This project to further explore and advance tremelimumab showcases our synergies in marrying world-class biologics expertise with global development and commercialization capabilities in oncology."
unknown title 2011
-
Pfizer says Debiopharm will run a new late-stage study of melanoma drug tremelimumab Pfizer enters melanoma partnership with DebiopharmNEW YORK - Pfizer Inc. said Thursday it is reviving development of its melanoma drug tremelimumab through a collaboration with Swiss drugmaker Debiopharm Group.
Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7 AP 2010
-
Pfizer says Debiopharm will run a new late-stage study of melanoma drug tremelimumab Pfizer enters melanoma partnership with DebiopharmNEW YORK - Pfizer Inc. said Thursday it is reviving development of its melanoma drug tremelimumab through a collaboration with Swiss drugmaker Debiopharm Group.
Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7 AP 2010
-
Pfizer says Debiopharm will run a new late-stage study of melanoma drug tremelimumab Pfizer enters melanoma partnership with DebiopharmNEW YORK - Pfizer Inc. said Thursday it is reviving development of its melanoma drug tremelimumab through a collaboration with Swiss drugmaker Debiopharm Group.
Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7 AP 2010
-
Pfizer says Debiopharm will run a new late-stage study of melanoma drug tremelimumab
Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7 AP 2010
-
Pfizer says Debiopharm will run a new late-stage study of melanoma drug tremelimumab
Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7 AP 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.